Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12626001127392Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial in hypotension comparing Calcium chloride infusion with Placebo saline infusion (2 arms). Primary endpoint: Recruitment rates. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12626001127392.